The heart failure frequent flyer: An urban legend

Clinical Cardiology

Volumn 32, Issue 2, 2009, Pages 67-68

  Mills, Roger M ^a  

^a SCIOS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; CANDESARTAN; TETRAZOLE DERIVATIVE;

ARTICLE; HEART FAILURE; HOSPITALIZATION; HUMAN; TREATMENT FAILURE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; HEART FAILURE; HOSPITALIZATION; HUMANS; TETRAZOLES; TREATMENT FAILURE;

EID: 70349907873     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20404     Document Type: Article

References (3)

1. Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJV, et al.: Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 2007;116:1482-1487 (Pubitemid 47480639)
2. Costanzo MR, Mills RM, Wynne J. Characteristics of "Stage D" heart failure: insights fromthe Acute Decompensated Heart Failure National Registry LongitudinalModule (ADHERE LM). Amer Heart J 2008;155:339-347
3. Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, et al.: Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Amer Coll Cardiol 2004;43:635-641 (Pubitemid 38229537)